FDA Inspection 883733 — Novo Nordisk Inc.
The FDA completed an inspection of Novo Nordisk Inc. on June 19, 2014 in Plainsboro, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 19, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Plainsboro, NJ (United States)
Additional Details
Sponsor, Contract Research Organization